Protein

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

5 days ago   |   By Xconomy

Vertex Pharmaceuticals is halting work on an experimental drug for a rare protein deficiency after safety problems were reported in Phase 2 testing. The study was evaluating the small molecule, VX-814, as a treatment for alpha-1 antitrypsin deficiency, which can lead to liver and lung problems. After the markets closed Wednesday, Vertex disclosed that elevated liver enzymes-eight times greater than normal--were observed in four of the patients who received the drug i. The placebo-controlled study enrolled approximately 50 patients. The liver enzyme levels are resolved or are resolving but...
Read more ...

 


Search by Tags

   Protein      Drug      Enzymes      Drugs      Pharmaceuticals      Pharmaceutical      Boston      Boston blog main      Boston top stories      National blog main      National top stories      Alpha-1 antitrypsin      Arrowhead Pharmaceuticals      Biotech      Clinical trials      Cystic Fibrosis      FDA      Geoffrey Porges      Life Sciences      Rare diseases      RNA Interference      SVB Leerink      Takeda Pharmaceutical      Vertex Pharmaceuticals  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Explicación sobre estudios de terapias experimentales contra la COVID-19

Explicación sobre estudios de terapias experimentales contra la COVID-19

Según queda claro después de meses de pandemia, la COVID-19 afecta a la gente de varias maneras. Algunos pueden infectarse y no presentar síntomas , mientras otros tienen... Read more ...

Toxic Cellular Ooze Linked to Biological Age, Disease and Disability

Toxic Cellular Ooze Linked to Biological Age, Disease and Disability

Cells in the body usually do what they're told. In response to cues, cells divide, grow, shrink or die as needed. But there are some cells that start to ignore the body's order... Read more ...

Aging and Immune Decline: Destiny or Dynamic?

Aging and Immune Decline: Destiny or Dynamic?

Aging is typically linked with the point in time when it causes problems. But there are many types of aging. There's chronological age, which we celebrate each year, sometimes... Read more ...

Berkeley Lab Building Efficiency Campaign Drives $95M in Annual Energy Savings

Berkeley Lab Building Efficiency Campaign Drives $95M in Annual Energy Savings

By Natalie Pawelski One hundred and four U.S. companies, schools, governments, and institutions are taking their building energy savings to a new level with the Department of... Read more ...

Chasing Their Tails but Getting Somewhere: Reimagining the Shape of Noise...

Chasing Their Tails but Getting Somewhere: Reimagining the Shape of Noise Leads to Improved Molecular Models

Univ. of Tennessee undergrad Elliot Perryman worked with Biosciences staff scientist Peter Zwart during his fall 2019 Berkeley Lab Undergraduate Research internship. Tenacity... Read more ...

WFH Series: Kestrel McCorkle

WFH Series: Kestrel McCorkle

As we navigate this interesting time of working from home, we asked a few GreenLighter's what their tips and tricks are staying inspired and connected with co-workers. This... Read more ...

Associate Scientist, Biologics Analytical Operations, Oceanside, CA - Gilead...

Gilead provides a work environment free of harassment and prohibited conduct. Demonstrate ability to learn new techniques/knowledge quickly.From Indeed - Wed, 21 Oct 2020... Read more ...

Emergent BioSolutions: Specialist I, QA

Emergent BioSolutions: Those who join Emergent BioSolutions feel a sense of ownership about their future. You will excel in an environment characterized by respect... Read more ...

Repairing the photosynthetic enzyme Rubisco

Manajit Hayer-Hartl, head of the research group "Chaperonin-assisted Protein Folding," has a long-standing interest in the central enzyme of photosynthesis called Rubisco. Her... Read more ...

Integrative analysis of key candidate genes and signaling pathways in...

Summary Cytotoxic T lymphocyte-associated antigen-4 , the first immune checkpoint to be targeted clinically, has provided an effective treatment option for various... Read more ...